CC2019: Management of Peritoneal Malignancies: Emerging Data in Heated Intraperitoneal Chemotherapy (HIPEC) and Other Strategies (C)

This session has been identified and designated as Credit to Meet ACS Accreditation/Verification Requirements for Cancer. Learn more about ACS Accreditation/Verification Requirements.

Session Description

A number of recent international randomized controlled trials have investigated the efficacy of cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal malignancies. Recent trials have demonstrated a benefit of CRS HIPEC in patients with ovarian cancer, and several highly anticipated trials are expected to report results in colorectal and gastric cancer in 2018. Based on this emerging data, CRS HIPEC results in improved long-term outcomes in select patients with peritoneal carcinomatosis who have traditionally been managed nonoperatively. This session will provide an update to the surgical community regarding which patients should be referred and considered for CRS HIPEC, with a focus on appropriate patient selection, sequencing of multimodality therapy, and long-term patient outcomes. The session will conclude with a case-based panel discussion.

Moderator: Garrett M. Nash, MD, FACS, New York, NY

Co-Moderator: Rebecca A. Snyder, MD, MPH, Greenville, NC

Presentations

Role of HIPEC in Colorectal Cancer: Pro
Olivier Glehen, MD, Pierre Benite, France

Role of HIPEC in Colorectal Cancer: Con
H. Richard Alexander, MD, FACS, New Brunswick, NJ

Role of HIPEC in Gastric Cancer
Brian D. Badgwell, MD, FACS, Houston, TX

Role of HIPEC for Ovarian Cancer
Oliver Zivanovic, MD, New York, NY

Sponsored by the ACS Clinical Research Program Education Committee

Target Audience

  • Practicing surgeons
  • Residents

Learning Objectives

  • Apply new knowledge and ideas to improve their surgical practice
  • Adapt concepts and quality measures in support of research advancements
  • Enhance the quality of patient care

Contact

For questions about the course, please contact elearning@facs.org.

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Self Assessment Credit
  • 1.50 Certificate of Completion
Course opens: 
11/15/2019
Course expires: 
01/05/2021

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any commercial interest. For additional information, please visit the ACCME website.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during a activity, please report it on the evaluation.

(Download the full list of disclosures).

Faculty and Disclosures

Brian D. Badgwell MD, FACS - Nothing to Disclose
Garrett M. Nash MD, FACS - Nothing to Disclose
H. Richard Alexander, Jr. MD, FACS - Nothing to Disclose
Oliver Zivanovic MD - Nothing to Disclose
Olivier Glehen, MD, PhD - Gamida: Consulting Fees and Travel: Consultant
Rebecca A. Snyder MD, MPH - Nothing to Disclose

Program Committee and Disclosures

CHAIR: Henri R. Ford, MD, MHA, FACS, FAAP, FRCSEng(Hon), Miami, FL - Nothing to Disclosure
VICE-CHAIR: David T. Cooke, MD, FACS, Sacramento, CA - Nothing to Disclosure

Members

David C. Borgstrom, MD, FACS, Morgantown, WV - Nothing to Disclosure
Daniel L. Dent, MD, FACS, San Antonio, TX - Nothing to Disclosure
Roger R. Dmochowski, MD, FACS, Nashville, TN - Allergen: Honoraria: Consultant
Cynthia D. Downard, MD, FACS, Louisville, KY - Nothing to Disclosure
Audra A. Duncan, MD, FACS, London, ON - Nothing to Disclosure
Mariam F. Eskander, MD, Boston, MA - Nothing to Disclosure
Paula Ferrada, MD, FACS, Richmond, VA - Nothing to Disclosure
Neil H. Hyman, MD, FACS, Chicago, IL - Nothing to Disclosure
Martin S. Karpeh, Jr., MD, FACS, New York, NY - Nothing to Disclosure
Dennis H. Kraus, MD, FACS, New York, NY - Nothing to Disclosure
Kenneth W. Sharp, MD, FACS, Nashville, TN - Nothing to Disclosure

Ex-Officios

Daniel M. Herron, MD, FACS, FASBMS, New York, NY - Nothing to Disclosure
Edith Tzeng, MD, FACS, Pittsburgh, PA - Nothing to Disclosure

Consultants

Barbara Lee Bass, MD, FACS, FRCSEng(Hon), FRCSI(Hon), FCOSECSA(Hon), Houston, TX - Nothing to Disclosure
Quan-Yang Duh, MD, FACS, San Francisco, CA - Nothing to Disclosure
B. J. Hancock, MD, FACS, FRCSC, Winnipeg, MB - Nothing to Disclosure
Ronald V. Maier, MD, FACS, FRCSEd(Hon), Seattle, WA - Nothing to Disclosure

Continuing Medical Education Credit Information

Accreditation

The American College of Surgeons is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™

The American College of Surgeons designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, a maximum of 1.5 credits meets the requirements for Self-Assessment.

American College of Surgeons and ACGME Logos

Note: Residents will receive a Certificate of Completion.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Self Assessment Credit
  • 1.50 Certificate of Completion

Accreditation Period

Course opens: 
11/15/2019
Course expires: 
01/05/2021
Please login or register to take this course.

This course is available as part of the Clinical Congress 2019 Webcast Packages